Psychopharmacology and hyperactivity: The imperfect panacea

Publisher Website
Google Scholar
Abstract
This paper is an attempt to describe the heated controversy surrounding the pharmacological approach in the treatment of hyperactivity. The reader is exposed to the literature and its attempt to define hyperactivity. The author demonstrates how ambiguity exists not only in definition of terminology, but treatment approach. Three drug groups, psychostimulants, phenothiazines, and the tricyclics are evaluated in relation to attention span, and cognitive benefit. Short‐termed improved behavior and attention span have been noted in the literature, but consistent improved cognitive benefit has not been reported. There is little proof that medication is useful in treating learning problems in children.